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A convenient assay specific to lipid hydroperoxide in plasma is presented. Cytochrome c heme peptide ob- 
tained from Saccharomyces was found to emit a strong chemiluminescence with any hydroperoxide, but 
not with TBA-reactive substances. The benefit of measuring this luminescence using photon counting is dis- 
cussed with respect to in vivo lipid peroxidation. 
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1. INTRODUCTION 
Lipid peroxidation has been of great interest to 
biochemists and biologists due to its association 
with a number of physiological processes. The 
arachidonic cascade, for example, includes many 
types of lipid peroxides such as prostaglandins and 
leucotriene precursors. The hydroperoxides of un- 
saturated fatty acids were recently suggested to 
cause some diseases such as arteriosclerosis, 
diabetes mellitus, and essential hypertension [l-3]. 
For the analysis of lipid peroxides, thiobar- 
bituric acid (TBA) assay has been widely used to 
estimate the content of malondialdehyde (MDA) 
produced from the endoperoxide of lipids [4-81. It 
is also well known that aldehydes, sugars, and 
sialic acid can also react with TBA [9-l 11. These 
substances cause an overestimation of lipid perox- 
ide in biological tissues and plasmas. Many alter- 
native techniques for the assay of biological 
samples are susceptible to errors due to artifacts 
and side reactions [12-151. 
We present here a method for evaluating lipid 
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peroxide by decomposing it into active oxygen. 
The active oxygen is then quantitatively measured 
by sensitization with luminol using a highly sen- 
sitive photon counting system to observe the 
chemiluminescence directly. After a widespread 
search, cytochrome c heme peptide (CHP) was 
found to evolve active oxygen most efficiently. 
2. MATERIALS AND METHODS 
2.1. Materials 
Cytochrome c heme peptide (CHP) was 
prepared from Saccharomyces oviformis MS with 
digestive actions of trypsin and pepsin [16,17]. 
Superoxide dismutase (Sigma) was used to confirm 
the participation of active oxygen in the 
chemiluminescence process. Horseradish perox- 
idase (HRP) was also obtained from Sigma. t- 
Butyl hydroperoxide (t-BuOOH) and di-t-butyl 
peroxide were purchased from Nakarai Chemicals 
(Japan) and were purified by distillation under 
reduced pressure. Luminol of guaranteed grade 
(Sigma) was used without further purification. 
Arachidonic hydroperoxide (15-hydroperoxyeico- 
satetraenoic acid, HPETE) was prepared from 
arachidonic acid (Sigma) in a method similar to 
that of [18]. 
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2.2. Apparatus 3. RESULTS AND DISCUSSION 
Photon counting was carried out with a 2-inch 
photomultiplier (R-1333) in combination with a 
photon counter (C-1250) from Hamamatsu 
Photonics. The photomultiplier was cooled to 
- 20°C and was used under a fairly high potential 
(- 1482 V). The counts were processed with an 
B-bit microcomputer (IF 800, OK1 Electric) and 
stored on a floppy disk for further data analysis. 
The apparatus was designed to mix automatically 
the analyte with a mixture of luminol and CHP in 
a quartz cuvette in the dark at a selected 
temperature. 
Table 1 shows the chemiluminescent responses 
to peroxides and other substances which could 
contaminate or coexist with lipid hydroperoxide in 
plasma. Di-t-butyl peroxide was used as a model 
compound for endoperoxide (-O-O-) groups to 
estimate the specificity of the reaction using CHP. 
It is worth noting that no luminescent response was 
observed by the luminol-CHP combination for 
NaCl, glucose and aldehyde, while HRP shows an 
undesirably large chemiluminescent response. In 
other words, HRP is not highly specific to 
hydroperoxide. Similar results were found with 
other peroxidases. On the other hand, CHP, after 
sensitization by luminol, generates a chemilumin- 
escent reaction with any hydroperoxide. 
2.3. Assay of lipid hydroperoxide in plasma 
For the chemiluminescent assay of lipid 
hydroperoxide, plasma was added to a mixture of 
luminol and CHP (0.9pg/ml luminol and 
120 yg/ml CHP, pH 9.2 borate buffer) which had 
been previously saturated with an inert gas (e.g., 
Nz) and maintained at 37°C. Plasma was prepared 
in the usual manner by bleeding a 6-week-old 
mouse (BALB/cJ) or a 7-week-old rat (Wistar Im- 
amichi). TBA assay in plasma was performed in a 
manner similar to [15]. 
As the first step in the chemiluminescent process 
is expected to be the encounter of the hydroperox- 
ide with a CHP molecule, it is possible that 
luminescent efficiency could be lower for large 
hydroperoxide molecules. It is therefore necessary 
to examine the linearity of the luminescent signal 
against concentration using several lipid 
hydroperoxides. The signal for HPETE, an 
arachidonic hydroperoxide of biological impor- 
Table 1 
Luminescent responses (counts at peak) of peroxides and biologically fundamental substances 
Name 
Substance 
Concentration 
Luminescent intensity in cpsa 
Luminol-CHPb Luminol-HRPb 
Air NZ Air N2 
Background 
Hz0 
Buffer (pH 9.2) 
NaCl 
NaCl 
NaCl 
EtOH 
Glucose 
MDA 
t-Bu-00-t-Bu 
t-BuOOH 
15HPETE 
10 mM 
0.9% 
0.09% 
0.009% 
1 pmol/ml 
1 amol/ml 
1 flmol/ml 
0.02 pmol/ml 
0.1 pmol/ml 
0.02 amol/ml 
181 163 174 186 
288 225 3453 531 
575 282 6745 1402 
400 294 4803 3726 
258 226 3309 860 
238 221 3540 998 
274 447 5376 354 
243 329 2873 298 
787 398 14708 6004 
328 184 5307 1649 
99432 66 268 19973 10289 
19631 14435 18253 8076 
a Average of 3 experiments 
b Gas used for saturating the samples and purging the apparatus 
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Fig. 1. Chemiluminescent intensity (counts at peak) 
against concentration in the assay of HPETE with 
luminol-CHP. The concentrations of luminol and CHP 
were as indicated in section 2. The concentration of 
HPETE was determined independently by iodometries. 
tance, shows the same linearity (fig. 1) with concen- 
tration as was observed using t-BuOOH. This 
result strongly supports our belief that the 
chemiluminescent signal is dependent solely on the 
concentration of hydroperoxyl group (-OOH) and 
is not a function of the structure of the lipid 
hydroperoxide. 
The minimum sample volume for the assay was 
held at 50 ~1 to avoid data fluctuation due to the 
inhomogeneity of the plasma sample. The op- 
timum concentration was found to be 10 pg/ml in 
CHP. Under these conditions, the detection limit 
was estimated to be 2 nmol/ml lipid hydroperox- 
ide to yield a signal-to-noise ratio of 5. 
As mentioned in section 1, this chemilumines- 
cent method using CHP as a luminescence catalyst 
is a very convenient procedure, and permits a good 
estimate of the lipid hydroperoxide level to be ob- 
tained. The lipid hydroperoxide level in rats 
(Wistar Imamichi) and mice (BALB/cJ) was deter- 
mined to permit a comparison with TBA assay. 
The lipid hydroperoxide level in plasma has been 
found to be very high in mice and lower in rats, as 
shown in table 2. The lipid hydroperoxide level in 
plasma kept for several days at - 2°C showed that 
there was a significant decomposition of the lipid 
hydroperoxide in storage. On the other hand, 
MDA values determined by TBA assay showed 
constant values on the same samples. These facts 
substantiate that TBA-reactive substances in 
plasma show no response to this chemiluminescent 
assay. Many substances produced metabolically 
from lipids, e.g., PG GZ and PG HZ and other 
biological constituents, react positively to TBA 
assay. On the other hand, this chemiluminescent 
Table 2 
Comparisons of the hydroperoxide levels with MDA values in the same plasmas of mice and rats 
Individual 
1 
2 
3 
4 
5 
Mouse (BALB/cJ) Rat (Wistar Imamichi) 
LOOH value MDA value Individual LOOH value MDA value 
(nmol/ml) (nmol/ml) (nmol/ml) (nmol/ml) 
124 20 1 32 4.2 
100 34 2 26 2.5 
96 28 3 30 1.9 
90 21 4 12 7.0 
106 15 5 20 5.9 
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assay appears to evaluate the content of only the 
lipid hydroperoxide. 
In our preliminary experiments on mice fed with 
alloxan (75 mg/kg body wt per day), the lumines- 
cent assay showed no increase in the lipid 
hydroperoxide level, while TBA assay apparently 
showed an explosive increase in the concentration 
of TBA-reactive substances. These results could be 
interpreted by the increase of lipid endoperoxide, 
but not of lipid hydroperoxide. 
Therefore, in the investigation of physiological 
effect of a drug on in vivo peroxidation, this 
chemiluminescent assay can be a powerful method 
to evaluate precisely the mechanism of 
peroxidation. 
In conclusion, the method presented here gives 
definite quantitative information about the level of 
lipid hydroperoxide in plasma. The application of 
this method to a biochemical system such as 
microsomal lipid peroxidation was found more 
practical. Although the apparatus was designed to 
obtain high sensitivity and easy procedure, any 
commercial uminometer can be used for this pur- 
pose at the expense of somewhat high detection 
limit. 
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